Evidence map›Paper›PMID 22911865›Full record

ArticlePloS one2012

Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats.

Kento Kitada, Daisuke Nakano, Ya Liu, Yoshihide Fujisawa, Hirofumi Hitomi, Yuki Shibayama, Hirotaka Shibata, Yukiko Nagai, Hirohito Mori, Tsutomu Masaki and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Role of an Angiotensin II Type-1 Receptor (ATBiological trace element research · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Lack of PPARBioMed research international · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kento KitadaDepartment of Pharmacology, Kagawa University, Kagawa, Japan.
Daisuke Nakano
Ya Liu
Yoshihide Fujisawa
Hirofumi Hitomi
Yuki Shibayama
Hirotaka Shibata
Yukiko Nagai
Hirohito Mori
Tsutomu Masaki
Hiroyuki Kobori
Akira Nishiyama
Kagawa University · JPKeio University · JP

Funding

Intrarenal Augmentation of Angiotensinogen by Ang IIR01DK072408 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2006 to 2010
$1.2M
NIDDK NIH HHS R01 DK072408
6 · The paper itself

Abstract

backgroundMineralocorticoid receptor (MR) antagonists attenuate renal injury in salt-sensitive hypertensive rats with low plasma aldosterone levels. We hypothesized that oxidative stress causes MR activation in high-salt-fed Dahl salt-sensitive rats. Furthermore, we determined if MR activation persisted and induced renal injury, even after switching from a high- to a normal-salt diet. METHODS AND

findingsHigh-salt feeding for 4 weeks increased dihydroethidium fluorescence (DHE, an oxidant production marker), p22phox (a NADPH oxidase subunit) and serum and glucocorticoid-regulated kinase-1 (SGK1, an MR transcript) in glomeruli, compared with normal-salt feeding, and these changes persisted 4 weeks after salt withdrawal. Tempol treatment (0.5 mmol/L) during high-salt feeding abolished the changes in DHE fluorescence, p22phox and SGK1. Dietary salt reduction after a 4-week high-salt diet decreased both blood pressure and proteinuria, but was associated with significantly higher proteinuria than in normal control rats at 4 weeks after salt reduction. Administration of tempol during high-salt feeding, or eplerenone, an MR antagonist (100 mg/kg/day), started after salt reduction, recovered proteinuria to normal levels at 4 weeks after salt reduction. Paraquat, a reactive oxygen species generator, enhanced MR transcriptional activity in cultured rat mesangial cells and mouse podocytes.

conclusionsThese results suggest that oxidative stress plays an important role in glomerular MR activation in Dahl salt-sensitive rats. Persistent MR activation even after reducing salt intake could limit the beneficial effects of salt restriction.

Indexed as

AdrenalectomyAldosteroneAnimalsBiomarkersBlood PressureCyclic N-OxidesEthidiumFeeding BehaviorGenes, ReporterImmediate-Early ProteinsKidney GlomerulusLuciferasesMaleMesangial CellsMiceOxidative StressAldosteroneBiomarkersCyclic N-OxidesdihydroethidiumEthidiumImmediate-Early ProteinsLuciferasesProtein Serine-Threonine KinasesReceptors, MineralocorticoidSerum-Glucocorticoid Regulated KinasesSlc9a1 protein, ratSodium Chloride, DietarySodium-Hydrogen Exchanger 1Sodium-Hydrogen ExchangersSpin Labelstempol

Identifiers

PMID22911865
PMCPMC3404044
OpenAlexW2059152796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.